pharma · Triple Negative Breast Cancer (TNBC) · Mesothelin-Expressing Tumors · CNTX
Context Therapeutics
Context Therapeutics trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
Philadelphia, USA HQ
2015 Founded
26 Employees
Public company Type
CNTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Philadelphia, USA
- Founded
- 2015
- Employees
- 26
- Programs
- 8
- Drugs
- 7
- Patents
- 3
Context Therapeutics clinical trials
Registry index of 9 ClinicalTrials.gov studies linked to Context Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Context Therapeutics trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Context Therapeutics.
-
Letrozole — Phase 1
Clinical update -
Elacestrant — Phase 2
Clinical update -
Extended-release Onapristone — Phase 2
Clinical update -
CT-95 — Phase 1
Clinical update -
Onapristone — Phase 2
Clinical update -
Onapristone ER — Phase 2
Clinical update -
CT-202 — Phase 1
Clinical update -
CTIM-76 — Phase 1
Clinical update